Delivra Health BrandsDHBUF Days Payable is 78.47 as of Mar. 2026, which is 64% below its 10-year median of 217.24. The stock has 3 warning signs investors should review. Among 921 Drug Manufacturers companies, Delivra Health Brands ranks worse than 64.28% on this metric.
Delivra Health Brands Days Payable Historical Data
* Premium members only.
The historical data trend for Delivra Health Brands's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Delivra Health Brands's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Delivra Health Brands Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Delivra Health Brands's Days Payable distribution charts can be found below:
* The bar in red indicates where Delivra Health Brands's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Delivra Health Brands's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Delivra Health Brands (DHBUF) has a Days Payable of 78.47 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Delivra Health Brands and its competitors. This is 64% below median its historical median of 217.24. Over the past decade, Delivra Health Brands' Days Payable has ranged from 56.70 to 472.02. According to the industry distribution chart, Delivra Health Brands ranks #592 out of 921 companies in the Drug Manufacturers industry, placing it in the top 64.3%.
Is Delivra Health Brands' Days Payable too high?
Delivra Health Brands' current Days Payable of 78.47 is 64% below median its 10-year median of 217.24. Over the past 10 years, this metric has ranged from a low of 56.70 to a high of 472.02. The Drug Manufacturers industry median Days Payable is 90.69. Delivra Health Brands' value of 78.47 is 13.5% below this industry median. Based on the distribution chart, Delivra Health Brands ranks #592 out of 921 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does Delivra Health Brands' Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Delivra Health Brands ranks #592 out of 921 companies for Days Payable. This places Delivra Health Brands in the lower half of its industry. The industry median Days Payable is 90.69. Delivra Health Brands' value of 78.47 is 13.5% below this benchmark. Historically, Delivra Health Brands' own Days Payable has ranged from 56.70 to 472.02 over the past decade. While the company's 10-year median is 217.24 vs. the industry median of 90.69, Delivra Health Brands has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.69, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Delivra Health Brands's current Days Payable of 78.47 is 13.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Delivra Health Brands and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Delivra Health Brands's current Days Payable is 78.47, which is 64% below median its own 10-year median of 217.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delivra Health Brands stock overvalued right now?
Based on GuruFocus' analysis, Delivra Health Brands (DHBUF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.19, compared to a current price of $0.07 — trading 62.7% below its estimated fair value. The current Days Payable is 78.47, which is 64% below median its 10-year median of 217.24 and 13.5% below the Drug Manufacturers industry median of 90.69. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Delivra Health Brands (DHBUF), the current Days Payable is 78.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Delivra Health Brands Inc helping people take control of health with alternative wellness solutions. Its portfolio features brands like Dream Water and LivRelief that deliver relief from common, everyday issues like chronic pain, anxiety, and sleeplessness. The principal activities of the company are to provide lifestyle and health and wellness products to consumers and patients in regulated markets. The company geographically operates in Canada and United States, out of which it generates maximum revenue from Unites States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHBUF has been successfully added to your 